US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 23, 2024 (2 years ago)

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

What was recalled

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

Recalling firm
Eugia US LLC
NDC code
55150-239-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0555-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Dexamethasone recalls

See all